SCHEMBL7998474

SCHEMBL7998474

Nc1cccc(CC(=O)Nc2ccc(C(=O)O)cc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.53
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
KMT2A Q03164 7/20 0.52
MEN1 O00255 6/20 0.52
HDAC1 Q13547 3/20 0.50
HDAC3 O15379 2/20 0.50
HDAC2 Q92769 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.50
NCOR2 Q9Y618 1/20 0.50
GLS O94925 1/20 0.49
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA5A P35218 1/20 0.49
CA7 P43166 1/20 0.49
CA9 Q16790 1/20 0.49
CA14 Q9ULX7 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10160138 0.88 EPHX2 (0.69) EPHX2KMT2AMEN1HDAC1HDAC3
SCHEMBL7097847 0.83 EPHX2 (0.76) EPHX2NPC1RAB9AKMT2AMEN1
SCHEMBL1073026 0.81 KMT2A (0.57) EPHX2KMT2AMEN1HDAC1HDAC3
SCHEMBL10797671 0.81 CA1 (0.57) EPHX2KMT2AMEN1ALDH1A1GLS
SCHEMBL11627580 0.80 GAA (0.60) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL28543839 0.79 EPHX2 (0.46) EPHX2KMT2AMEN1HDAC1HDAC3
SCHEMBL3454266 0.79 EPHX2 (0.69) EPHX2NPC1RAB9AKMT2AMEN1
SCHEMBL13544615 0.79 EPHX2 (0.69) EPHX2NPC1RAB9AKMT2AMEN1
SCHEMBL11628339 0.79 NLRP3 (0.61) NPC1RAB9AKMT2AMEN1HDAC1
SCHEMBL22196106 0.78 KMT2A (0.78) EPHX2NPC1RAB9AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001074771-A1 PYRROLE-2,5-DIONE DERIVATIVES FOR THE TREATMENT OF DIABETES SMITHKLINE BEECHAM P.L.C. (GB) 2001-10-11 WO disclosed